Tarsus Pharmaceuticals Inc (TARS) valuation · rev $451.4M
Tarsus Pharmaceuticals Inc (TARS) rev $451.4M.
| Metric | Value |
|---|---|
| Market cap | $2.66B |
| Revenue | $451.4M |
| P/S | 5.9 |
| P/B | 7.7 |
TARS valuation FAQ
What is TARS's market cap?
Tarsus Pharmaceuticals Inc (TARS) market cap is $2.66B on the latest cached fundamentals snapshot.
What is TARS's latest revenue?
Latest cached Tarsus Pharmaceuticals Inc (TARS) revenue was $451.4M. Statements: https://lician.com/financials/tars
What is TARS's price-to-sales ratio?
Tarsus Pharmaceuticals Inc (TARS) price-to-sales (P/S) is 5.9, cached market cap $2.66B divided by revenue $451.4M.
What is TARS's price-to-book ratio?
Tarsus Pharmaceuticals Inc (TARS) price-to-book (P/B) is 7.7 on the latest cached fundamentals snapshot.
How many TARS valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Tarsus Pharmaceuticals Inc (TARS): Market cap, Revenue, P/S, and P/B.
Where is TARS valuation listed?
Cached valuation multiples for Tarsus Pharmaceuticals Inc (TARS) are listed at https://lician.com/valuation/tars.
Not investment advice. Cached rows, not a live tape.